Axon Enterprise (Nasdaq: AXON) reports its fourth-quarter 2025 results today after the market close, capping a year defined by aggressive ecosystem expansion and a stock that has pulled back sharply despite strong revenue growth.
A Year of Growth, a Stock Under Pressure
Axon’s Q3 set the tone for what investors expect heading into Q4. Revenue came in at $711 million, up 31% year-over-year, marking the seventh consecutive quarter of 30%-or-greater growth. But the EPS print told a different story. Reported EPS of $1.17 missed the $1.54 consensus estimate, and the company posted a GAAP net loss of $2 million as R&D investment and acquisition costs weighed on the bottom line.
The stock reacted hard. Shares fell 17% in the session following the Q3 report and have continued sliding. AXON is down roughly 24% year-to-date and off 29% over the past month, trading near $433 against a 52-week high of $885.92. That context makes this print more consequential than usual.
Consensus Estimates vs. Management Guidance
| Metric | Q4 2025 (Guidance) | Full Year 2025 (Guidance) |
|---|---|---|
| Revenue | $750M – $755M | ~$2.74B (~31% YoY growth) |
| Adj. EBITDA Margin | ~24% | ~25% (full-year target) |
| Normalized EPS Estimate | Not publicly disclosed | Not publicly disclosed |
Management did not provide formal EPS guidance for Q4. Given the Q3 pattern of heavy investment spending, investors should not assume bottom-line improvement without explicit commentary from the CFO.
Margins, Bookings, and the AI Era Plan
The central question tonight is whether Axon can demonstrate that its spending surge is translating into durable revenue expansion rather than margin erosion. Adjusted gross margin in Q3 was 62.7%, down 50 basis points year-over-year, primarily due to tariffs hitting the Connected Devices segment for a full quarter. CFO Brittany Bagley characterized that as a one-time reset, noting that as software scales, gross margin tailwinds should return over time.
I’ll be watching the Software and Services segment closely. It grew 41% year-over-year in Q3, reaching $305 million, with net revenue retention holding at 124% and ARR growing 41% to $1.3 billion. That trajectory needs to hold for the margin story to be credible.
Bookings momentum is the other key signal. CFO Joshua Isner said year-to-date bookings were up over 30% and accelerating, with Q4 expected to be a strong bookings quarter. The AI Era Plan has been the fastest-booked software product at Axon, with AI bookings on track to represent over 10% of U.S. state and local bookings for the full year. Any update on that figure will matter.
You should also watch for early results from the Axon Body Workforce Mini launch and the Prepared and Carbyne integrations. Management described enterprise as potentially the biggest part of the business long-term, and Q4 commentary on early enterprise traction could shift sentiment meaningfully.
Analyst consensus remains overwhelmingly bullish, with 18 buy ratings and just one hold, and a consensus price target of $783.68 implying significant upside from current levels. But 52 recent insider sales create a notable divergence worth monitoring as management speaks tonight.
Execution Is the Only Thing That Matters Now
Axon has built a compelling long-term narrative around ecosystem expansion, AI-driven software, and international cloud adoption. What the market needs tonight is evidence that the investment cycle is cresting and profitability is returning. A revenue beat near the top of guidance is table stakes. The real test is whether management can provide a credible path toward margin recovery in 2026 without pulling back on the growth investments that define this company’s next chapter.
Top Gaining Stocks
Top Losing Stocks